Meleshko Alexander N, Belevtsev Michael V, Savitskaja Tatjana V, Potapnev Michael P
Belarusian Research Center for Pediatric Oncology & Hematology, Scientific Department, P.O. Lesnoye, 223052 Minsk, Belarus.
Leuk Res. 2006 Jul;30(7):795-800. doi: 10.1016/j.leukres.2005.11.007. Epub 2006 Jan 4.
Immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangement is conventionally used for assessment of lymphoid malignant cells. TCR genes rearrangements were reported to occur at high frequency in B-lineage acute lymphoblastic leukemia (ALL). Therefore, we have analyzed 83 children with acute B-lineage ALL (67 de novo patients and 19 relapses) by PCR analysis for clonal IgH, incomplete TCRD (Vdelta2-Ddelta3 and Ddelta2-Ddelta3) and TCRG rearrangements. It was shown that clonal cross-lineage TCR rearrangements were associated with more immature immunophenotype (CD34+, CD117+, CyIgM-) of leukemic cells from patients' bone marrow (BM) samples as compared to cell samples without cross-lineage TCR rearrangements. That was equally detected both in de novo and relapsed cases of disease. Low frequency of clonal TCRG rearrangements was associated with expression of E2A/PBX chimeric oncogene. We suggest that TCRG and TCRD clonal rearrangements in leukemic B-cells are associated with early stages of their differentiation.
免疫球蛋白(Ig)和T细胞受体(TCR)基因重排传统上用于评估淋巴恶性细胞。据报道,TCR基因重排在B系急性淋巴细胞白血病(ALL)中高频发生。因此,我们通过PCR分析对83例急性B系ALL患儿(67例初发患者和19例复发患者)进行了克隆性IgH、不完全TCRD(Vδ2-Dδ3和Dδ2-Dδ3)和TCRG重排分析。结果显示,与无跨谱系TCR重排的细胞样本相比,克隆性跨谱系TCR重排与患者骨髓(BM)样本中白血病细胞更不成熟的免疫表型(CD34+、CD117+、CyIgM-)相关。在疾病的初发和复发病例中均同样检测到这一情况。克隆性TCRG重排的低频率与E2A/PBX嵌合癌基因的表达相关。我们认为白血病B细胞中的TCRG和TCRD克隆重排与其分化的早期阶段相关。